Hemolytic Anemia In Infants. Hemolytic anemia is a group of diseases the most characteristic of which is increased destruction of the blood cells caused by the reduction of their life. The aim of this study is to evaluate the clinical biological and hematological profiles of autoimmune hemolytic anemia aiha in children and to specify its etiologies therapeutic modalities and treatment responses. It s also called erythroblastosis fetalis. Clinicians should be facile in recognizing its presentation.
Main focus areas include acquired immune mediated hemolysis hemolytic anemia due to hereditary rbc disorders hereditary. 1 division of hematology oncology stanford university school of medicine california usa. Hemolytic anemia is a group of diseases the most characteristic of which is increased destruction of the blood cells caused by the reduction of their life. Many children do not need treatment. It s also called erythroblastosis fetalis. Hemolytic means breaking down of red blood cells.
Anemia is among the most frequent laboratory abnormalities encountered by a practicing pediatrician.
Anemia is caused by one of three broad mechanisms. Hemolytic anemia ha affects a substantial proportion of the pediatric population globally. This article provides an overview of hemolytic anemia in children. A combination of these mechanisms can occur simultaneously in some conditions. Hemolytic anemia is a group of diseases the most characteristic of which is increased destruction of the blood cells caused by the reduction of their life. This is a 14 year retrospective study of aiha cases collected at the department of pediatric emergency and reanimation of hedi chaker university.